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MicroRNAs (miRNAs) play key roles in gene expression regulation in both healthy and disease
brains. To better understand those roles, it is necessary to characterize the miRNAs that are
expressed in particular cell types under a range of conditions. In situ hybridization (ISH) can
demonstrate cell- and lamina-specific patterns of miRNA expression that would be lost in
tissue-level expression profiling. In the present study, ISH was performed with special focus
on the human entorhinal cortex (EC) and transentorhinal cortex (TEC). The TEC is the area of the
cerebral cortex that first develops neurofibrillary tangles in Alzheimer’s disease (AD). However,
the reason for TEC’s special vulnerability to AD-type pathology is unknown. MiRNA ISH was
performed on three human brains with well-characterized clinical and pathological parameters.
Locked nucleic acid ISH probes were used referent to miR-107, miR-124, miR-125b, and miR320. In order to correlate the ISH data with AD pathology, the ISH staining was compared with
near-adjacent slides processed using Thioflavine stains. Not all neurons or cortical lamina stain
with equal intensity for individual miRNAs. As with other areas of brain, the TEC and EC have
characteristic miRNA expression patterns. MiRNA ISH is among the first methods to show
special staining characteristics of cells and laminae of the human TEC.
Keywords: hippocampus, neurodegeneration, Alzheimer, brain, ncRNA, RNA, neuron, NFT

INTRODUCTION
Alzheimer’s disease (AD) is a prevalent neurodegenerative disease that culminates in severe deficits in cognition and autonomy.
By definition, brains afflicted by AD contain two different neuropathological hallmarks – neurofibrillary tangles (NFTs) and
neuritic amyloid plaques (NPs) The National Institute on Aging,
and Reagan Institute Working Group on Diagnostic Criteria for
the Neuropathological Assessment of Alzheimer’s Disease (1997).
NFTs are ‘inclusion bodies’, composed of insoluble tau protein polymers that coalesce within neurons. NPs consists a roughly-spherical
extracellular component that includes fibrillary polymers of the Aβ
peptide, with nearby degenerating cell processes that contain tau
polymers indistinguishable from those in NFTs.
Neuroanatomically, AD pathology manifests in a complex but
well-characterized spatiotemporal sequence (Braak and Braak,
1991; Braak et al., 1993). Most clinico-pathological correlation
studies indicate that cortical NFT density, assessed by Braak staging
(Braak et al., 1993) or other means, is the parameter best correlated
with the severity of AD cognitive impairment (Arriagada et al.,
1992; Nelson et al., 2007b, 2008a,b, 2009b; Sonnen et al., 2007). In
the first stages of the disease, NFTs are observed in medial temporal
lobe structures (Braak and Braak, 1991).
The specific cerebral cortical subfield with earliest NFT formation in AD is the transentorhinal cortex (TEC) (Braak and Braak,
1992). The TEC usually occupies the medial bank of the perirhinal
collateral sulcus, comprising ∼2–10 mm of the inexactly defined and
phylogenetically variable Brodmann Area 35 (Schmidt et al., 1993;
Taylor and Probst, 2008). As its name implies, the TEC constitutes a
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transitional zone between the entorhinal cortex (EC) and the more
laterally situated six-layered cerebral isocortex (Braak and Braak,
1985). The TEC thus “can be considered a periallocortical field bordering a proisocortical field of the adjacent temporal cortex, that
corresponds to the perirhinal region”, according to Heiko Braak
and colleagues (Schmidt et al., 1993). NFTs are observed in the TEC
long before clinical manifestations of AD: in a large autopsy series,
scant numbers of NFTs were detected in the TEC of approximately
one-fifth of persons dying in their thirties and over one-third of
persons in their forties (Del Tredici and Braak, 2008).
During the progression toward end-stage AD, NFTs and/or
cell death claim the large majority of neurons in some laminae
of the TEC and nearby EC (Braak and Braak, 1985; Gomez-Isla
et al., 1996; Garcia-Sierra et al., 2000; Hof et al., 2003). NFTs
are also observed in the TEC and EC in neurodegenerative diseases other than AD: Parkinson’s disease, argyrophilic grain disease, and Huntington’s disease, for example (Braak and Braak,
1992; Ulrich et al., 1992; Braak et al., 2000; Nelson et al., 2009a).
Unfortunately, the remarkable predisposition of TEC and EC
neurons to develop pathological changes has not been adequately
explained. Nor are there many reported markers providing clues
about TEC neurochemistry.
In the present study, in situ hybridization (ISH) was performed in
order to characterize the distribution of some neuronally-expressed
microRNAs (miRNAs) in the human TEC and surrounding brain
structures. MiRNAs are short (∼22 nucleotide) RNA molecules
that play fundamental roles in gene expression regulation in all
known plants and animals. In particular, miRNAs are known
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to serve key functions in neurodevelopment, synaptic plasticity,
and neuroprotection (Kosik and Krichevsky, 2005; Cuellar et al.,
2008; Smalheiser and Lugli, 2009). MiRNAs may have potentiated mammalian brain evolution by amplifying the complexity
of nervous system gene expression regulation (Nelson and Keller,
2007; Heimberg et al., 2008). On the other hand, miRNAs also
contribute to human illnesses, particularly in the pathogenesis of
human neurodegenerative disease (Nelson et al., 2008b; Hebert
and De Strooper, 2009). ISH shows important cerebral cortical
lamina-specific patterns of miRNA expression that would be lost
on most tissue-level expression studies (Mellios et al., 2008; Nelson
and Wilfred, 2009), and these lamina-specific miRNA expression
patterns could be relevant to AD (Wang et al., 2008).
We chose to study four miRNAs that are expressed in human
brain:
(1) miR-107, which we have shown may be relevant to AD pathogenesis and traumatic brain injury, and which may be involved
in metabolic regulation (Wilfred et al., 2007; Wang et al., 2008;
Redell et al., 2009; Tang et al., 2009).
(2) miR-124, which is highly enriched in neurons and plays
many important roles in neuronal gene expression regulation
(Smirnova et al., 2005; Krichevsky et al., 2006; Makeyev et al.,
2007; Tang et al., 2007).
(3) miR-125b, which is expressed in many different cell types
including the mammalian brain and which has been proposed
to play a number of complex nervous system roles (Smirnova
et al., 2005; Lukiw and Pogue, 2007; Ferretti et al., 2008; Le
et al., 2009a,b).
(4) miR-320, which is highly expressed in neurons and glial cells
and which is dysregulated in prion disease (Nelson et al.,
2007a; Saba et al., 2008).

MATERIALS AND METHODS
Brain tissue was obtained from University of Kentucky ADC Brain
bank using appropriate IRB protocols. Details of subject recruitment, autopsies, and other analyses using the University of Kentucky
ADC autopsy series are described elsewhere (Nelson et al., 2007b,
2008a). Criteria for inclusion in this study included post-mortem
intervals (PMIs) under 5 h. Brain sections from two individuals
without antemortem cognitive decline were included (Cases 1 and
2), and a third person with early AD (Case 3). Demographic and
pathological parameters of each of the three cases used for this
study are shown in Table 1.

Human brain ISH methods have been published (Nelson et al.,
2006; Wang et al., 2008; Nelson and Wilfred, 2009). Very briefly,
post-mortem human brain sample was obtained via autopsy
within 5 h of death. Tissue portions that included the EC were
used. Brain tissues were fixed in 4% paraformaldehyde overnight
at 4oC and then immersed in 20% sucrose (4oC) for an additional
24–48 h. Tissue was cut to 25 microns on a freezing microtome
and mounted onto premarked Superfrost® Plus slides. Cut tissue sections were allowed to air-dry for 30 min. The slides were
then transferred to a −80oC freezer, until subsequent processing as described. Digoxigenin-labeled locked nucleic acid probes
(Exiqon, Woburn MA) were used and their presence visualized
via anti-digoxigenin immunohistocyhemistry using protocols
described in detail previously (Wang et al., 2008; Nelson and
Wilfred, 2009).
Histological stains were performed on near-serial sections that
were fixed, cut, mounted, and frozen along with the sections used for
ISH. Thioflavine S (Polysciences, Inc., Warrington, Pennsylvania)
was used as a 1% aqueous solution followed by differentiation in
two changes of 80% ethanol. Nissl staining was accomplished using
0.1% Cresyl violet solution that was filtered immediately before
use. After staining for 5 min, sections were differentiated in 95%
ethanol and cleared in xylenes.

RESULTS
Sections of human TEC and EC were evaluated using miRNA ISH
and several histological stains. Photomicrographs from each of the
three cases are presented in Figures 1–3. These show ISH results
for miR-107, miR-124, miR-125b, and miR-320 in the TEC and
nearby structures in correlation to AD pathology (Thioflavine S
stained NFTs and NPs).
Since miR-320 and miR-124 showed distinctive cortical laminar
staining in the TEC, a separate panel (Figure 4) shows the ISH
results for near-serial section using miR-320 and miR-124 ISH and
Thioflavine S from Case 3. Note that the Thioflavine S-stained
NFT-bearing neurons are present in a band of cells that are relatively lacking in ISH stain for both miR-124 and miR-320. For both
miR-124 and miR-320, there is an immediately more superficial
band of cells that are labeled. As can be seen in Figures 1–3, the
staining pattern in and near the TEC is relatively consistent with
regard to this staining pattern of cells – the layer of miR-124 cells
appears particularly characteristic. MiR-107 stains less strongly
than the other probes. As expected, miR-125b, and to a lesser degree
miR-107 and miR-320, appear to stain glial cells in addition to

Table 1 | Information about cases used in the current study including demographic, cognitive testing, post-mortem interval, Consortium to
Establish A Registry for Alzheimer’s Disease (CERAD) neuritic plaque, Braak neurofibrillary stages, and apolipoprotein E (ApoE) alleles.
Sex

Case 1

Age at

Final MMSE

Months since

Post-mortem

CERAD

Braak

death

score

final MMSE

interval (hrs)

score

stage

ApoE

F

79

29

9

1.75

No

0–I

3/3

F

94

27

5

2.33

No

II

3/3

M

76

27

32

4.25

Definite

VI

3/4

(Non-demented)
Case 2
(Non-demented)
Case 3 (AD)
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FIGURE 1 | In situ hybridization, Nissl, and Thioflavine S stains for Case 1.
(A) Nissl stain (B) miR-107 ISH (C) miR-125b ISH (D) miR-320 ISH (E) miR-124
ISH, and (F) Thioflavine S (amyloid plaques and neurofibrillary tangles are

fluorescent.) In this case, there were no amyloid plaques and a few scattered
neurofibrillary tangles, which are indicated with arrows in the transentorhinal
cortex. Scale bar = 1000 microns. D = dorsal, M = medial, V = ventral, L = lateral.
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FIGURE 2 | In situ hybridization, Nissl, and Thioflavine S stains for Case 2. (A) Nissl stain (B) miR-107 ISH (C) miR-125b ISH (D) miR-320 ISH (E) miR-124 ISH,
and (F) Thioflavine S (amyloid plaques and neurofibrillary tangles are fluorescent.). TEC indicated with arrows. Scale bar = 1200 microns. D = dorsal, M = medial,
V = ventral, L = lateral.
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FIGURE 3 | In situ hybridization, Nissl, and Thioflavine S stains for Case 3.
(A) Nissl stain (B) miR-107 ISH (C) miR-125b ISH (D) miR-320 ISH (E) miR-124
ISH (band of stained cells indicated with black arrow), and (F) Thioflavine S
(amyloid plaques and neurofibrillary tangles are fluorescent.). In this case there

neurons. In some of the sections there was artifactual staining in
the white matter that was trimmed out of the photomicrographs.
To see what the staining in the white matter looks like, please see
SupplementaryMaterial.
Figure 5 provides a more comprehensive picture of the EC and
the nearby subiculum. ISH shows results using probes for miR-320,
miR-124, and miR-125b in Case 1. Note that the layer II (“pre-α”)
EC “islands” are relatively strongly labeled for miR-124, whereas
the the superficial portions of the pre-, para-, and pro-subiculum
are somewhat more strongly labeled for miR-125b. This pattern
was also seen in other cases (data not shown).

DISCUSSION
ISH using a set of probes against brain-enriched miRNAs was used
to assess cellular miRNA expression in the human TEC and surrounding structures. These data have both technical and theoretical
implications. From a technical standpoint, the present study further
underscores the importance of ISH as a technique to complement
tissue-level miRNA expression profiling. The pattern of miRNA

Frontiers in Human Neuroscience

was extensive Alzheimer’s-type pathology with both amyloid plaques and
neurofibrillary tangles. A band of neurofibrillary tangles, near the miR-124
positive cell band from the nearby section, is indicated with a pink arrow. Scale
bar = 1200 microns. D = dorsal, M = medial, V = ventral, L = lateral.

expression also helps to refine the expectations for miRNA functions
in the brain, in both normal and disease conditions. The pattern
of ISH labeling in the human cerebral cortex affirms that defining
individual miRNAs as “neuronal” or “non-neuronal” is overly simplistic, because different populations of neurons – even within a tiny
cell layer – can have distinct miRNA expression profiles.
There are some limitations to the current study. ISH is a relatively
low-throughput technique and thus we only were able to thoroughly
evaluate the results using a handful of miRNA probes, and brain sections from only three individuals’ brains (all of these patients were
elderly Caucasians). Although the results were consistent among the
cases evaluated, it is possible that study of a larger population would
result in greater variability or even completely disparate results. Also,
it has been shown that post-mortem degradation of miRNAs in the
human brain can be rapid and can affect different miRNAs at different rates (Sethi and Lukiw, 2009). In the current study we used
brains that had relatively short PMIs (less than 5 h). However, using
cases with even shorter PMIs may have revealed a different staining
pattern. Finally, the technique that we used employs both ISH and
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A

*

+ Thioflavin

A

S

B

miR125b

pre-α
B

miR320

C

D

miR320

C

miR124

Case 3
FIGURE 4 | Comparison in staining patterns using ISH with miRNA
probes and Thioflavine S on Case 3. Photomicrographs from sections
stained with miR-124 (A) and miR-320 (C) were overlaid with near-serial
sections stained with Thioflavine S (B and D). Note that for both miR-124 and
miR-320, it is layers with a relative paucity of ISH stain (arrows on the left) that
are most intensely stained with the Thioflavine S (arrows on the right). Pial
surface is indicated in A with an asterisk. Scale bar = 300 microns.

immunohistochemistry (anti-digoxigenin antibody is used to detect
the digoxigenin-labeled RNA probe). Like the great majority of histochemical staining methods, ISH is not a rigorously quantitative
technique for evaluating gene expression. This is because of the many
variables in tissue processing that are impossible to control between
cases and even between different sections of the same case. As such it
is more appropriate to evaluate critically the staining pattern, rather
than the more detailed characteristics of staining intensity in any given
section. We also are dissatisfied with employing near-serial sections
to define correlative staining patterns. Hence we are investigating the
use of double-label methods to enable, in the future, more definite
determination of human brain miRNA co-expression patterns.
Despite the limitations inherent to this type of study, the ISH
technique reveal consistent staining patterns in the human cerebral
cortex. The TEC itself is a small (<1 cm) but highly intriguing cortical subfield, being most developed in the human relative even to
other primate species (Braak et al., 2000; Taylor and Probst, 2008).
Perhaps most interesting is the cell population that seems to “dive”
from the superficial layer II neurons of the EC, through the entire
depth of layer III in the TEC, to approximate layer V neurons in the
“temporal proneocortex” (Braak and Braak, 1985, 1992). These are
apparently the neurons most vulnerable to NFT development in the
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D
L

M
V

FIGURE 5 | In situ hybridization of entorhinal cortex (layer pre-α is noted)
and pre-, para- and pro-subiculum (S) using probes against miRNAs (A)
miR-125b (B) miR-320, and (C) miR-124. All stains were performed on Case
1. Scale bar = 1500 microns.

human cerebral cortex. These particular neurons show an apparent
lack of high amounts of both miR-124 and of miR-320. The impact
of these expression patterns are currently not understood. They
may relate in some way with the remarkable dendritic plasticity
shown by TEC and EC neurons (Arendt et al., 1998). However,
neurons in the nearby pre-α (layer II) of the EC proper, which is
also affected relatively early in AD, express high amounts of both
miR-320 and miR-124. There are of course many other miRNAs
with expression patterns overlaid on those of miR-107, miR-125b,
miR-124, and miR-320. For all of these, the lamina-specific expression characteristics would not be possible to evaluate using most
tissue-level expression profiling platforms.
In conclusion, we have demonstrated novel miRNA expression
patterns in the human TEC and EC. Neurodegenerative diseases
tend to affect these cell populations for reasons that currently are
poorly understood. MiRNAs are important components of a neuron’s gene expression repertoire. Each neuronal subpopulation may
express a distinct fraction of the uniquely-human miRNome. Thus,
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future directions for study of miRNAs should include more human
brain ISH. With the help of these “descriptive” studies we can better understand the relevant mechanisms of miRNAs in health and
in disease states.
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